Thymol Increases Sensitivity of Clinical Col-R Gram-Negative Bacteria to Colistin
Zhuocheng Yao, Luozhu Feng, Yining Zhao, Xiaodong Zhang, Lijiang Chen, Lingbo Wang, Ying Zhang, Yao Sun, Tieli Zhou, Jianming Cao
Abstract
Colistin is being considered “the last ditch” treatment in many infections caused by multidrug-resistant GNB clinical isolates, but colistin-resistant (Col-R) strains with different drug resistance mechanisms have appeared worldwide. Hence, it is of great significance to rejuvenate sensitization of clinical Col-R Gram-negative bacteria to colistin.
Topics & Concepts
ColistinGram-negative bacterial infectionsGram-negative bacteriaMicrobiologyAntibioticsDrug resistanceBiologyBacteriaGramMCR-1Multiple drug resistanceMedicineEnterobacteriaceaeGeneticsEscherichia coliGeneAntibiotic Resistance in BacteriaBacterial biofilms and quorum sensingAntibiotic Use and Resistance